Everolimus Tablet
Product Images NDC 70377-010

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 70377-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2.5 mg Everolimus Tablets

The text contains information about Everolimus Tablets with different strengths and packaging sizes from two different manufacturers: Reonly and Sbiocon. The NDC number for the tablets is 70377-010-22. The tablets come in 28 tablet packs, and each tablet contains 2.5 mg everolimus. The rest of the text includes some gibberish characters, making it difficult to comprehend.*

FDA Label Image

Everolimus Structure

FDA Label Image

Everolimus Tablets 5mg

NDC 70377-011-22 identifies a medicine known as Everolimus Tablets I, which comes in 28 tablets containing each 5 mg of Everolimus. It is RxOnly and is produced by Biocon. The given text also mentions Everolimus Tablets EEE, also produced by Biocon, which is again Rxonly and comes in 28 tablets. The rest of the given text contains gibberish and cannot be evaluated.*

FDA Label Image

Everoliomus Tablets 10mg

NDC 70377-013-22 is a prescription drug that contains 10mg of everolimus per tablet, and comes in a pack of 28 tablets.*

FDA Label Image

Fig 1

The text describes the Progression-Free Survival Probability of patients taking Everolimus 10mg with exemestane compared to those taking Placebo-exemestane. The Kaplan-Meier medians show a significant difference with 7.8 months median for Everolimus 10mg - exemestane and 32 months median for Placebo-exemestane. The Logrank p value was <0001. The graph shows data for the censoring times of patients in both groups over a period of 28 months.*

FDA Label Image

Everolimus Tablets 7.5 mg

The text contains information about a medicine called Everolimus Tablets I, with a strength of 7.5 mg per tablet. The package contains 28 tablets, and the product is available only with a prescription (Rxonly). The NDC (National Drug Code) number of the product is 70377-012-22. The remaining characters appear to be non-English and do not provide any useful information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.